Coroventis Coroflow Cardiovascular System

Used with Abbott's PressureWire™ X Guidewire, the Only Solution for the Cath Lab Able to Detect Both Epicardial Disease and Microvascular Dysfunction1-3

Flexible Installation Options

The Coroventis CoroFlow Cardiovascular System, with touch screen usability, can be installed on hospital-owned PCs or delivered on preconfigured platforms. Pre-configured platforms include an integrated workstation and a mobile battery powered cart.

CoroFlow Cardiovascular System Only

  CoroFlow cardiovascular system
  • CoroHub Receiver
  • USB Cable
  • CoroFlow Software + CoroHub Drivers
  • Remote with USB Receiver + Batteries

What's provided: Coroventis CoroFlow System only; hospital provides PC

Advantages: No additional control room/cath lab space needed



CoroFlow Cardiovascular System + Micro PC workstation

  CoroFlow Cardiovascular System
  • Control Room Monitor
  • Micro PC installed with CoroFlow Software
  • CoroHub Receiver

What's provided: Micro PC that comes installed with software

Advantages: Fully "integrated" into control room/cath lab



CoroFlow Cardiovascular System + Mobile Touch Screen PC

  Coroflow cardiovascular system cart
  • Cart PC installed with CoroFlow Software
  • CoroHub Receiver
  • Mobile Cart Stand

What's provided: Mobile cart and PC that comes installed with software

Advantages: Supports multiple cath labs with a touch interface


Minimal PC Requirements

The minimum PC requirements include:
CPU: Intel Core i5 or higher
Ports: 2 Free USB 2.0 ports
Operating system: Windows 10
Screen: Full HD (1920 x 1080)
Optional access to shared network drive or Cloud allows for centralized data storage


Refer to Instructions For Use (IFU) for additional information.
 

References

  1. Data on file at Abbott
  2. Ford TJ, Stanley B, Sidik N, et al. 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). JACC Intv. 2020; 13:33-45.
  3. Pijls NH, Fearon WF, Tonino PA, et al. Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients with Multivessel Coronary Artery Disease. 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study. JACC. 2010; 56(3): 177-184.

MAT-2114954 v1.0